Overview

Colorado-Oregon Altitude Study

Status:
Completed

Trial end date:
2023-01-01

Target enrollment:

Participant gender:

Summary

Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.

Phase:

Phase 4

Details

Lead Sponsor:

University of Oregon

Treatments:

Epoetin Alfa
Ferric Oxide, Saccharated